4-HO-PiPT
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C16H24N2O |
Molar mass | 260.381 g·mol−1 |
3D model (JSmol) | |
| |
|
4-Hydroxy-N-propyl-N-isopropyltryptamine (4-HO-PiPT, Piprocin) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It acts as a 5-HT2A receptor agonist, with an EC50 of 13.8 nM and an efficacy of 104.8% (vs 5-HT),[1] and has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.[2]
See also
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-DSBT
- 4-HO-EiBT
- 4-HO-McPT
- 4-HO-McPeT
- 5-MeO-PiPT
- Ebalzotan
- Propylisopropyltryptamine
References
- ^ Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115167
- ^ Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia's Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Tryptamines
- All stub articles
- Nervous system drug stubs